Generic Name: Desvenlafaxine
Pristiq is a brand name for the drug desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI). It is an extended release formulation believed to treat depression by affecting the levels of serotonin and norepinephrine, two neurotransmitters associated with depression.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Depression | 66 |
|
|
|
|
|
19 |
| Treat my mood condition(s) | 28 |
|
|
|
|
9 | |
| Major Depressive Disorder | 14 |
|
|
3 | |||
| Bipolar Disorder | 11 |
|
|
2 | |||
| Anxiety | 10 |
|
|
|
4 | ||
| Other | 7 |
|
|
|
3 |
See all 124 patients currently taking Pristiq
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
15 | 42% |
|
|
Side effects too severe
|
14 | 39% |
|
|
Expense
|
6 | 17% |
|
|
Other
|
6 | 17% |
|
|
Doctor's advice
|
5 | 14% |
|
|
Personal research
|
2 | 6% |
|
Report created on November 21, 2009.